Ken Drazan, M.D., Managing Director
ken@bertramcapital.com
Ken oversees Healthcare Services investments.  Previously, Ken was the CEO and founder of Arginox Pharmaceuticals.  Earlier in his career, Ken was a leading academic liver transplant surgeon and basic scientist at Stanford University and UCLA. 

Ken currently serves as Chairman of Arginox Pharmaceuticals and Kuratek Incorporated.

State University of New York
Doctor of Medicine, cum laude

Yale University
Bachelor of Arts in Economics, cum laude